FDA approves CO2 laser for hard-tissue use

The U.S. Food and Drug Administration (FDA) has cleared Convergent Dental's Solea for ablation of hard tissue for caries removal and cavity preparation.

Solea is the first CO₂ laser technology system to receive FDA clearance for hard tissue indications, the company noted in a press release. Earlier this year, the company gained FDA clearance for soft tissue indications using the Solea.

Solea is the first 9.3-micron CO₂ computer-aided preparation dental laser system on the market that uses pulsed energy and other patented technologies to cut hard tissue and perform incision, excision, vaporization, coagulation, and hemostasis of soft tissue in the oral cavity, according to Convergent.